8-K: Orgenesis Inc. Faces Nasdaq Delisting, Appoints New Board Members

Orgenesis Inc. is set to be delisted from the Nasdaq Stock Market and has appointed three new members to its Board of Directors.

Summary

• Orgenesis Inc. received notification from Nasdaq on October 17, 2024, that it will be delisted from the exchange.
• The delisting process will involve Nasdaq filing a Form 25 with the SEC, with the delisting becoming effective 10 days after the filing.
• Deregistration of the company's common stock under Section 12(b) of the Exchange Act will occur 90 days after the Form 25 filing, or sooner if the SEC determines.
• The company's stock began trading on the OTCQX market on October 21, 2024.
• On October 28, 2024, the company appointed Adam Pelavin, Jagannathan Bhalaji, and Santhosh Nagaraj to the Board of Directors.
• The board size was increased from four to seven members to accommodate the new appointments.
• Each new director will receive a stock option to purchase 625 shares, vesting over three years, and an annual cash retainer of $30,000.
• Each director will also receive an annual stock option to purchase 125 shares.
• The company intends to enter into Securities Purchase Agreements with Mr. Bhalaji and Mr. Nagaraj, with their board appointment being a condition of closing.

Sentiment

Score: 3

Explanation: The delisting from Nasdaq is a major negative event, overshadowing the positive addition of new board members. The overall sentiment is negative due to the significant loss of prestige and potential investor confidence.

Positives

• The appointment of three new directors could bring fresh perspectives and expertise to the Board.
• The company's stock is now trading on the OTCQX market, providing continued trading access for investors.

Negatives

• The delisting from Nasdaq is a significant negative event for the company.
• The delisting could reduce the company's visibility and potentially impact investor confidence.

Risks

• The delisting from Nasdaq could lead to decreased trading volume and liquidity for the company's stock.
• The company may face challenges in raising capital due to the delisting.
• The transition to the OTCQX market may not be as favorable as being listed on Nasdaq.

Future Outlook

The company will continue to operate on the OTCQX market after delisting from Nasdaq. The company intends to enter into Securities Purchase Agreements with two of the new directors.

Industry Context

Delisting from a major exchange like Nasdaq can be a significant setback for a company, often leading to reduced investor interest and potentially impacting future growth prospects. Companies that are delisted often move to over-the-counter markets.

Comparison to Industry Standards

• Delisting from Nasdaq is generally viewed negatively, as it can indicate financial or compliance issues. Many companies that are delisted from major exchanges struggle to regain their listing status.
• The move to the OTCQX market is a common path for companies that are delisted, but it typically results in lower trading volumes and less institutional investor interest.
• The appointment of new board members is a common practice for companies undergoing significant changes, but the timing of these appointments in conjunction with the delisting is unusual.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders will be impacted by the delisting from Nasdaq and the move to the OTCQX market.
• The company's employees may experience uncertainty due to the delisting.
• The company's creditors may be concerned about the company's financial stability.

Next Steps

• Nasdaq will file Form 25 with the SEC to initiate the delisting process.
• The delisting will become effective 10 days after the Form 25 filing.
• The company will continue to trade on the OTCQX market.
• The company will enter into Securities Purchase Agreements with Mr. Bhalaji and Mr. Nagaraj.

Key Dates

Keywords

delisting, Nasdaq, OTCQX, board of directors, stock options, corporate governance, securities purchase agreement